BRIEF published on 11/20/2024 at 07:05, 3 days 3 hours ago Claudius Moor Appointed as New CEO of Arbonia CEO Appointment Arbonia AG Corporate Leadership Claudius Moor Swiss Industry
BRIEF published on 11/20/2024 at 07:05, 3 days 3 hours ago Claudius Moor Appointed New CEO of Arbonia Corporate Strategy Doors Division Executive Transition Arbonia CEO Claudius Moor
PRESS RELEASE published on 11/20/2024 at 07:00, 3 days 3 hours ago Claudius Moor will be the new CEO of Arbonia Claudius Moor appointed as the new CEO of Arbonia Group, succeeding Alexander von Witzleben. Moor, a Swiss citizen, has a background in business administration and extensive experience within the company CEO Arbonia Claudius Moor Swiss Citizen Business Administration
PRESS RELEASE published on 11/20/2024 at 07:00, 3 days 3 hours ago Claudius Moor will be the new CEO of Arbonia Arbonia AG appoints Claudius Moor as new CEO, succeeding Executive Chairman Alexander von Witzleben. Moor, a Swiss citizen, has a background in BCG and has been with Arbonia since 2015 CEO Arbonia AG Executive Chairman Claudius Moor Swiss Citizen
BRIEF published on 09/27/2024 at 18:05, 1 month 25 days ago Arbonia Appoints Uwe Schiller as New Chief Financial Officer (CFO) Board Of Directors Chief Financial Officer Strategic Reorientation Arbonia Uwe Schiller
PRESS RELEASE published on 09/27/2024 at 18:00, 1 month 25 days ago Arbonia appoints Uwe Schiller as new Chief Financial Officer (CFO) Arbonia AG appoints Uwe Schiller as new Chief Financial Officer (CFO) in strategic move. Schiller brings extensive experience to the role Chief Financial Officer CFO Appointment Arbonia AG Uwe Schiller
BRIEF published on 08/27/2024 at 07:05, 2 months 27 days ago Arbonia AG Reports Steady Revenue and Increased Profit Margins for H1 2024 Market Conditions Doors Division H1 Results Arbonia 2024 EBITDA Increases
PRESS RELEASE published on 08/27/2024 at 07:00, 2 months 27 days ago Press release Arbonia AG reports stable revenue in H1 2024 despite challenging market conditions. Doors Division maintains revenue level while increasing EBITDA margin. Acquisitions diversify end markets and expand product portfolio Acquisitions EBITDA Margin Arbonia AG Doors Division Revenue Stability
BRIEF published on 06/20/2024 at 07:05, 5 months 3 days ago Arbonia Sells “Zelgstrasse” Site in Arbon to HRS Group for CHF 34 Million EBITDA Real Estate Transaction Arbonia HRS Group
PRESS RELEASE published on 06/20/2024 at 07:00, 5 months 3 days ago Arbonia sells the “Zelgstrasse” site in Arbon to the HRS Group for around CHF 34 million Arbonia AG sells the 'Zelgstrasse' site in Arbon to HRS Group for around CHF 34 million, leading to positive financial effects. The site is fully leased and part of the company's strategy Real Estate Arbonia AG HRS Group Zelgstrasse Arbon
Published on 11/22/2024 at 23:55, 10 hours 36 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 1 minute ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 26 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 1 minute ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 37 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 35 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 31 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
